Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T16:02:08.746Z.
Calculation as of: 2026-10-06T16:02:08.746Z.
Quote observation: 2026-10-06T15:57:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 83c838c5f02617604a06e7cb0420d823d591f860cb8694f5d9431dbed4021aaa
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$2.73M
EV/EBITDA Ratio
N/A
TTM Avg
2.90x
3Y Avg
908.27x
5Y Avg
908.27x
Market Cap
$2.92M
EV/EBITDA Ratio
N/A
TTM Avg
371.60x
3Y Avg
252.16x
5Y Avg
252.16x
Market Cap
$2.30M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DEFSEC Technologies Inc. (DFSC) | $2.75M | N/A | N/A | N/A | N/A |
| Globavend Holdings Limited (GVH)vs › | $2.73M | N/A | 2.90x | 908.27x | 908.27x |
| Top KingWin Ltd. Class A (DPU)vs › | $2.73M | N/A | N/A | N/A | N/A |
| BioNexus Gene Lab Corp. (BGLC)vs › | $2.92M | N/A | 371.60x | 252.16x | 252.16x |
| PTL Limited (PTLE)vs › | $3.03M | N/A | N/A | N/A | N/A |
| Intelligent Group Limited (INTJ)vs › | $3.10M | N/A | N/A | N/A | N/A |
| Polar Power, Inc. (POLA)vs › | $3.12M | N/A | 23.18x | 14.28x | 33.49x |
| Ping An Biomedical Co., Ltd. (PASW)vs › | $2.30M | N/A | N/A | N/A | N/A |
| Mint Incorporation Limited (MIMI)vs › | $2.16M | N/A | N/A | N/A | N/A |
| Iveda Solutions, Inc. (IVDA)vs › | $3.34M | N/A | 155.22x | 155.22x | 155.22x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute